Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, BROWN & BROWN, INC. insiders bought a net $164.1K of stock across 34 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-27.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 50.0% of the 5,353 shares held after it.
1 other insider bought within 30 days.
443 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director KRUMP PAUL J bought about $249.9K of BRO on Aug 8, 2025, the largest insider purchase at the company since 2023; 1 other insider bought within 30 days and 443 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Jun 21, 2023.
The trade is 20.0% of the 5,000 shares held after it.
1 other insider bought within 30 days.
443 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Masojada Bronislaw Edmund bought about $91.4K of BRO on Aug 6, 2025, the largest insider purchase at the company since 2023; 1 other insider bought within 30 days and 443 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BRO planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
BRO mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Clarkston Fund
$1.4M position · as of 2026-06-30
4.5%
FAM VALUE FUND
$80.7M position · as of 2026-06-30
4.4%
Madison Mid Cap Fund
$70.2M position · as of 2026-07-31
4.1%
Mid Cap Fund
$3.8M position · as of 2026-06-30
3.8%
Invesco KBW Property & Casualty Insurance ETF
$8.3M position · as of 2026-05-31
3.4%
Motley Fool Mid-Cap Growth ETF
$3.9M position · as of 2026-05-31
3.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · J. Powell Brown
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$8.6M
-$6.0M
$3.7M
+74%
+84%
2024
$11.7M
$39.1M
$4.0M
+121%
+95%
2023
$9.8M
$23.9M
$3.3M
+53%
+60%
2022
$6.7M
-$5.3M
$4.7M
+22%
+45%
2021
$9.2M
$32.8M
$3.5M
+49%
+41%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $164.1K bought by insiders over 180 days, 443 funds added last quarter, 3 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.8B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM BRO
FY Dec 2025
$5.9B
FY Dec 2024
$4.8B
FY Dec 2023
$4.3B
FY Dec 2022
$3.6B
FY Dec 2021
$3.1B
Jun 2026
$1.7B
Mar 2026
$1.9B
Dec 2025
$1.6B
Sep 2025
$1.6B
Jun 2025
$1.3B
Mar 2025
$1.4B
Dec 2024
$1.2B
Sep 2024
$1.2B
At each fiscal year end
Single quarter
Net margin, TTM
+17.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM BRO
FY Dec 2025
+17.8%
FY Dec 2024
+20.7%
FY Dec 2023
+20.5%
FY Dec 2022
+18.8%
FY Dec 2021
+19.2%
Jun 2026
+17.2%
Mar 2026
+22.4%
Dec 2025
+16.4%
Sep 2025
+14.1%
Jun 2025
+18.0%
Mar 2025
+23.6%
Dec 2024
+17.8%
Sep 2024
+19.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.4B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM BRO
FY Dec 2025
$1.4B
FY Dec 2024
$1.1B
FY Dec 2023
n/a
FY Dec 2022
$829.0M
FY Dec 2021
$763.8M
Jun 2026
$329.0M
Mar 2026
$241.0M
Dec 2025
$424.0M
Sep 2025
$452.0M
Jun 2025
$310.0M
Mar 2025
$196.0M
Dec 2024
$341.0M
Sep 2024
$417.0M
At each fiscal year end
Single quarter
Debt to equity
0.62x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity BRO
FY Dec 2025
0.61x
FY Dec 2024
0.59x
FY Dec 2023
0.68x
FY Dec 2022
0.86x
FY Dec 2021
0.48x
Jun 2026
0.62x
Mar 2026
0.62x
Dec 2025
0.61x
Sep 2025
0.62x
Jun 2025
0.65x
Mar 2025
0.56x
Dec 2024
0.59x
Sep 2024
0.55x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.20x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt BRO
FY Dec 2025
0.19x
FY Dec 2024
0.31x
FY Dec 2023
0.27x
FY Dec 2022
0.22x
FY Dec 2021
0.40x
Jun 2026
0.20x
Mar 2026
0.19x
Dec 2025
0.19x
Sep 2025
0.18x
Jun 2025
0.18x
Mar 2025
0.36x
Dec 2024
0.31x
Sep 2024
0.31x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+9.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity BRO
FY Dec 2025
+11.1%
FY Dec 2024
+16.5%
FY Dec 2023
+17.1%
FY Dec 2022
+15.3%
FY Dec 2021
+14.8%
Jun 2026
+9.9%
Mar 2026
+11.8%
Dec 2025
+11.1%
Sep 2025
+10.6%
Jun 2025
+11.4%
Mar 2025
+16.3%
Dec 2024
+16.5%
Sep 2024
+18.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets BRO
FY Dec 2025
+4.4%
FY Dec 2024
+6.1%
FY Dec 2023
+6.0%
FY Dec 2022
+5.7%
FY Dec 2021
+6.3%
Jun 2026
+4.3%
Mar 2026
+4.9%
Dec 2025
+4.4%
Sep 2025
+4.3%
Jun 2025
+4.8%
Mar 2025
+6.5%
Dec 2024
+6.1%
Sep 2024
+6.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital BRO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed BRO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
22.42x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing BRO
FY Dec 2025
24.91x
FY Dec 2024
29.49x
FY Dec 2023
23.24x
FY Dec 2022
24.04x
FY Dec 2021
33.95x
Jun 2026
20.24x
Mar 2026
20.97x
Dec 2025
24.91x
Sep 2025
28.08x
Jun 2025
31.95x
Mar 2025
34.65x
Dec 2024
29.49x
Sep 2024
28.23x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$30.6B
market value at close 2026-10-26 on 2026-07-24 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value BRO
FY Dec 2025
$33.7B
FY Dec 2024
$32.3B
FY Dec 2023
$23.3B
FY Dec 2022
$19.4B
FY Dec 2021
$21.2B
Jun 2026
$28.6B
Mar 2026
$29.0B
Dec 2025
$33.7B
Sep 2025
$37.5B
Jun 2025
$30.4B
Mar 2025
$38.7B
Dec 2024
$32.3B
Sep 2024
$32.2B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield BRO
FY Dec 2025
+5.1%
FY Dec 2024
+3.7%
FY Dec 2023
n/a
FY Dec 2022
+5.1%
FY Dec 2021
+3.8%
Jun 2026
+6.7%
Mar 2026
+6.4%
Dec 2025
+5.1%
Sep 2025
+4.2%
Jun 2025
+4.0%
Mar 2025
+3.6%
Dec 2024
+3.7%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -9%, PEG needs growth
PEG, trailing BRO
FY Dec 2025
n/a
FY Dec 2024
2.26x
FY Dec 2023
0.80x
FY Dec 2022
1.66x
FY Dec 2021
1.51x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
3.31x
Dec 2024
2.26x
Sep 2024
0.72x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BRO ranks highest on insider conviction (85th percentile) and growth (72nd), and lowest on risk and compliance (22nd), among Insurance peers.
Profitability
49
Inputs
Return on equity+9.9% · 33 pct, sector of 116
Return on assets+4.3% · 64 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
23
Inputs
Debt to equity0.62x · 21 pct, sector of 104
Cash flow to debt0.20x · 24 pct, sector of 97
Growth
72
Inputs
Revenue growth, YoY+22.8% · 72 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
85
Inputs
Net Form 4 buying (codes P and S), 180d$164K · 84 pct, sector of 100
Insider buyers, 180d2 · 87 pct, sector of 101
Institutional and government
42
Inputs
Funds adding, latest quarter443 · 83 pct, sector of 108
Congress net buyers, 365d-3 · 1 pct, universe of 719
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
22
Inputs
Short interest, % of float+4.9% · 34 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+22.8% · 9 pct, sector of 110
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BRO filings, in plain words
Are Brown & Brown insiders buying or selling BRO?
In the 180 days to 2026-10-27, Brown & Brown insiders were net buyers, a net $164.1K across purchases and sales reported on Form 4, by 2 buyers.
Have members of Congress traded BRO?
Yes. In the year to 2026-10-27, 3 House members disclosed buying BRO and 6 House members disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-08-25.
Read the full summary
In the 180 days to 2026-10-27, Brown & Brown insiders were net buyers of BRO, a net $164.1K across purchases and sales reported on Form 4 by 2 buyers. In the year to 2026-10-27, 3 members of Congress disclosed buying BRO and 6 members disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-08-25. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.